Skip to content
10-Q

Quarterly Report

IRIS BIOTECHNOLOGIES INC

0001554795-14-000508

← back to feed
Filed
Aug 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 14, 2014 14.97M sh
Stockholders Equity Q2 2014 · Jun 30, 2014 $132.27K
Stockholders Equity Q2 2014 · Dec 31, 2013 −$184.05K
Current Liabilities Q2 2014 · Jun 30, 2014 $241.08K
Current Liabilities Q2 2014 · Dec 31, 2013 $191.24K
Total Liabilities Q2 2014 · Jun 30, 2014 $254.08K
Total Liabilities Q2 2014 · Dec 31, 2013 $207.24K
Current Assets Q2 2014 · Jun 30, 2014 $379.95K
Current Assets Q2 2014 · Dec 31, 2013 $18.99K
Total Assets Q2 2014 · Jun 30, 2014 $386.35K
Total Assets Q2 2014 · Dec 31, 2013 $23.2K
Shares Diluted Q2 2014 · Jun 30, 2013 14.2M sh
Shares Diluted Q2 2014 · Jun 30, 2013 14.17M sh
Operating Cash Flow Q2 2014 · Jun 30, 2013 −$53.15K
Cash And Equivalents Q2 2014 · Jun 30, 2013 $1.1K
Cash And Equivalents Q2 2014 · Dec 31, 2012 $1.04K
Sga Expense Q2 2014 · Jun 30, 2013 $100.33K
Sga Expense Q2 2014 · Jun 30, 2013 $196.37K
Rd Expense Q2 2014 · Jun 30, 2013 $7.12K
Rd Expense Q2 2014 · Jun 30, 2013 $11.76K
Net Income Q2 2014 · Jun 30, 2013 −$109.98K
Net Income Q2 2014 · Jun 30, 2013 −$213.1K
Operating Income Q2 2014 · Jun 30, 2013 −$108.89K
Operating Income Q2 2014 · Jun 30, 2013 −$211.05K